HYYDF - The Hydropothecary Corporation

Other OTC - Other OTC Delayed Price. Currency in USD
3.3451
-0.0048 (-0.1433%)
At close: 3:56PM EDT
Stock chart is not supported by your current browser
Previous Close3.3499
Open3.3688
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range3.3188 - 3.3899
52 Week Range3.3188 - 3.3899
Volume200,713
Avg. VolumeN/A
Market Cap580.753M
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)-0.1610
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • This Under-the-Radar Pot Stock Just Secured Canada's Largest Supply Agreement
    Motley Fool4 days ago

    This Under-the-Radar Pot Stock Just Secured Canada's Largest Supply Agreement

    Previously announced recreational cannabis supply agreements are peanuts next to this deal.

  • The Cannabis Sector: Mergers, Acquisitions, and Price Upgrades
    Market Realist4 days ago

    The Cannabis Sector: Mergers, Acquisitions, and Price Upgrades

    The cannabis sector remains hot for mergers and acquisitions as companies rush to capture a piece of the recreational cannabis market. Last week, Canopy Growth (WEED) announced that it had acquired Annabis Medical, an importer and distributor of medical cannabis in the Czech Republic. Last week, Cannabis Wheaton announced its acquisition of a licensed producer in Nova Scotia, Robinson’s Cannabis, which is constructing a 27,700-square-foot facility ahead of the legalization of recreational cannabis in Canada.

  • Hydropothecary: Analyst Ratings and Price Target in April
    Market Realist8 days ago

    Hydropothecary: Analyst Ratings and Price Target in April

    Hydropothecary (HYYDF) continued its upward momentum and closed 1.5% higher on April 12, 2018. The company and its peers (MJ) Canopy Growth (WEED), Aphria (APHQF), MedReleaf (MEDFF), and Aurora Cannabis (ACB) completed supply agreements with SAQ (Société des alcools du Québec). You can find out more at Why Hydropothecary Stock Rose 13% Yesterday.

  • Why Hydropothecary Stock Rose 13% Yesterday
    Market Realist9 days ago

    Why Hydropothecary Stock Rose 13% Yesterday

    On April 11, Hydropothecary (HYYDF) stock surged 13.2% after it became the SAQ’s (Société des alcools du Québec) preferred non-medical cannabis supplier once non-medical cannabis becomes legal in Canada. The company’s press release stated that the agreement term extends to the first five years following legalization and has an option to extend for another year.

  • 5 Marijuana Stocks From a Budding Industry
    InvestorPlace10 days ago

    5 Marijuana Stocks From a Budding Industry

    Emerging businesses often serve as excellent chances to earn outsized profits. One rising out of the shadows recently is the marijuana industry. Bans instituted in the early 20th century drove its cultivation and use of cannabis underground. However, with various trends toward legalization, marijuana stocks have gained interest from investors.

  • Hydropothecary’s Operating Expense Swells in Fiscal 2Q18
    Market Realist19 days ago

    Hydropothecary’s Operating Expense Swells in Fiscal 2Q18

    Hydropothecary (HYYDF) reported a fall during fiscal 2Q18 due to a big increase in its operating expense YoY (year-over-year). The company’s operating expense rose from 1.7 million Canadian dollars in fiscal 2Q17 to 5.5 million Canadian dollars in fiscal 2Q18. Standardizing this as a percentage of its sales, Hydropothecary’s operating expenses rose from 1.9x its sales in fiscal 2Q17 to 4.6x its sales in fiscal 2Q18.

  • Hydropothecary’s Selling Price per Gram Drops in Fiscal 2Q18
    Market Realist21 days ago

    Hydropothecary’s Selling Price per Gram Drops in Fiscal 2Q18

    Key Takeaways from Hydropothecary's Fiscal 2Q18 Earnings

  • A Perspective on Hydropothecary’s Revenue Visibility
    Market Realist21 days ago

    A Perspective on Hydropothecary’s Revenue Visibility

    Earlier in this series, we learned that Hydropothecary (HYYDF) experienced a 29% YoY (year-over-year) increase in sales in its fiscal 2Q18. Driving this sales figure higher was the 45% YoY growth in the medical cannabis space. In all, the company sold 132,000 grams (or ~132 kilograms) of medical cannabis during the quarter.

  • Key Takeaways from Hydropothecary’s Fiscal 2Q18 Earnings
    Market Realist21 days ago

    Key Takeaways from Hydropothecary’s Fiscal 2Q18 Earnings

    Key Takeaways from Hydropothecary's Fiscal 2Q18 EarningsFiscal 2Q18 earnings

  • March Top Growth Companies
    Simply Wall St.23 days ago

    March Top Growth Companies

    Companies that have significant growth prospects for profitability and returns can add tangible upside to your portfolio. Real Matters and Distinct Infrastructure Group are examples of many potential outperformers thatRead More...

  • What Happened in the Cannabis Sector Last Week
    Market Realist26 days ago

    What Happened in the Cannabis Sector Last Week

    What Happened in the Cannabis Sector Last WeekCannabis ETFs tumbled last week

  • Your Cannabis Sector Update for the Week Ended March 16
    Market Realistlast month

    Your Cannabis Sector Update for the Week Ended March 16

    Your Cannabis Sector Update for the Week Ended March 16Sector ETFs

  • Factors Expected to Influence the Provinces’ Supplier Decisions
    Market Realistlast month

    Factors Expected to Influence the Provinces’ Supplier Decisions

    Ahead of the legalization of recreational cannabis, companies are ramping up their production capacities. Currently, Canada has a total of 91 licensed producers, of which 48 are in the province of Ontario. How a province goes about selecting its supplier will be critical for big and small players alike.

  • Manitoba and Quebec Announced Cannabis Retailers and Suppliers
    Market Realist2 months ago

    Manitoba and Quebec Announced Cannabis Retailers and Suppliers

    Key Developments in the Cannabis Sector Last Week

  • Key Developments in the Cannabis Sector Last Week
    Market Realist2 months ago

    Key Developments in the Cannabis Sector Last Week

    Key Developments in the Cannabis Sector Last WeekThe week ending February 16

  • Benzinga2 months ago

    Investing In Marijuana: Cannabis Industry Gets $1.2B In January, Matching Deals For All Of 2016

    Interest in who is investing in the marijuana industry is mounting rapidly, and not without a reason. Over the first five weeks of 2018, the  Viridian Cannabis Deal Tracker registered $1.23 billion in ...

  • Hydropothecary Announces Upsize of Previously Announced Offering
    CNW Group3 months ago

    Hydropothecary Announces Upsize of Previously Announced Offering

    Hydropothecary Announces Upsize of Previously Announced Offering

  • Hydropothecary Announces $100 Million Public Offering
    CNW Group3 months ago

    Hydropothecary Announces $100 Million Public Offering

    Hydropothecary Announces $100 Million Public Offering

  • Newsfile4 months ago

    CFN Media Exclusive CEO Interview: Hydropothecary's Strategic Presence, Dual Focus Set It Apart

    Seattle, Washington--(Newsfile Corp. - December 7, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an exclusive CEO interview and article discussing The Hydropothecary Corporation (TSXV: THCX) and its focus on developing award-winning products while also scaling up cannabis production capacity in a province that could give it near-exclusive supply rights.Strategic Presence in QuebecCanada's projected growth in the cannabis industry is driven by ...

  • Newsfile5 months ago

    Hydropothecary's Decarb Could Change the Way Cannabis is Consumed - CFN Media

    Seattle, Washington--(Newsfile Corp. - November 8, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article covering the innovative product lines offered by The Hydropothecary Corporation (TSXV: THCX), focusing on the Decarb product line comprised of fine milled, activated medical marijuana powders.Canada's cannabis industry is expected to reach $22.6 billion in size over the coming years, according to Deloitte, driven by the ...

  • Hydropothecary Announces Upsize of Previously Announced Offering
    CNW Group6 months ago

    Hydropothecary Announces Upsize of Previously Announced Offering

    Hydropothecary Announces Upsize of Previously Announced Offering

  • Newsfile6 months ago

    Hydropothecary is Quebec's Only Licensed Producer - CFN Media

    Seattle, Washington--(Newsfile Corp. - October 19, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing the Hydropothecary Corporation (TSXV: THCX) and its unique position in the burgeoning cannabis industry. Canada's cannabis industry is expected to balloon to C$22.6 billion over the coming years, according to Deloitte, following the legalization of adult-use cannabis. With about 60 licensed producers approved by Health ...

  • CNW Group10 months ago

    Hydropothecary Announces Upsize of Previously Announced Bought Deal Private Placement Financing to $25.0 million

    Hydropothecary Announces Upsize of Previously Announced Bought Deal Private Placement Financing to $25.0 million

  • PR Newswire10 months ago

    Hydropothecary Announces Upsize of Previously Announced Bought Deal Private Placement Financing to $25.0 million

    As previously announced, each convertible debenture unit will consist of $1,000 principal amount of 8.0% senior unsecured convertible debentures of the Company (the "Convertible Debentures") and 313 common share purchase warrants (the "Warrants") of the Company (the "Offering").  The Convertible Debentures will bear interest from the date of closing at 8.0% per annum, payable semi-annually on June 30 and December 31 of each year and will mature on June 30, 2019 (the "Maturity Date"). The Convertible Debentures will be convertible at the option of the holder into common shares of the Company at any time prior to the close of business on the Maturity Date at a conversion price of $1.60 per share (the "Conversion Price").